Volume 11, Number 2—February 2005
Dispatch
In Vitro Host-Cell Susceptibility to Usutu Virus
Figure 2
![Demonstration of Usutu virus antigen 3 days postinfection. Immunohistochemical (IHC) tests were performed by using a polyclonal antibody to West Nile virus, which cross-reacts with Usutu virus. A) Vero control; B) Vero infected; C) CR (feline) control; D) CR infected; E) goose embryo fibroblast (GEF) control; F) GEF infected; A,B) bar = 50 μm; C–F) bar = 100 μm. †3 days postinfection (p.i.), IHC staining.](/eid/images/04-1016-F2.jpg)
Figure 2. Demonstration of Usutu virus antigen 3 days postinfection. Immunohistochemical (IHC) tests were performed by using a polyclonal antibody to West Nile virus, which cross-reacts with Usutu virus. A) Vero control; B) Vero infected; C) CR (feline) control; D) CR infected; E) goose embryo fibroblast (GEF) control; F) GEF infected; A,B) bar = 50 μm; C–F) bar = 100 μm. †3 days postinfection (p.i.), IHC staining.
1This study will be presented at the International Conference on Emerging Infectious Diseases, February 26–March 3, 2005, Al Ain, United Arab Emirates
Page created: April 27, 2011
Page updated: April 27, 2011
Page reviewed: April 27, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.